Amylyx Pharmaceuticals AMLX Cash Flow Statement (2021-2026)

NASDAQ AMLX
$38.60 +3.49 (+9.94%)
At close: Aug 19, 2026 · 4:00 PM UTC
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-23.14M-28.32M-47.85M-54.09M-53.76M-43.81M1.57M22.07M20.89M2.70M-118.79M-72.70M-72.70M25.51M-35.91M-41.44M-34.39M-33.00M-90.95M-121.94M
Depreciation and Depletion (Quarter)
0.01M0.02M0.04M0.10M0.17M0.18M0.20M0.28M0.30M0.30M0.32M0.21M0.22M0.16M0.16M0.14M0.12M0.11M0.10M0.04M
Share-based Compensation (Quarter)
0.80M1.09M4.96M5.71M5.52M16.76M7.50M9.95M10.18M9.53M9.92M9.57M6.80M6.74M6.83M7.35M23.93M6.39M12.30M8.32M
Change in Interest Receivables (Quarter)
0.00M0.01M0.05M-0.55M-0.25M0.61M-0.73M0.35M-0.12M-0.30M0.12M-0.06M-0.07M-0.01M0.06M-0.01M
Cash from Operations (Quarter)
-20.86M-28.24M-40.63M-46.46M-43.08M-49.70M-5.07M8.61M-5.17M13.55M-0.49M-66.58M-41.57M-59.01M-39.82M-25.25M-30.37M-27.90M-36.88M-31.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.10M-0.00M0.11M0.09M1.86M2.90M1.98M2.48M2.57M2.58M3.18M2.31M1.79M1.70M1.52M1.24M1.06M0.61M1.22M
Depreciation & Amortization (CF) (Quarter)
0.01M0.02M0.04M0.10M0.17M0.18M0.20M0.28M0.30M0.30M0.30M0.20M0.20M0.20M0.20M0.10M0.10M0.10M0.10M0.10M
Change in Working Capital
Change in Receivables (Quarter)
15.17M2.25M15.92M-4.12M10.70M-19.70M-16.26M-2.36M-1.28M-0.15M-0.20M0.03M-0.04M
Change in Inventory (Quarter)
9.21M13.30M19.33M14.01M26.48M9.25M
Change in Account Payables (Quarter)
0.16M1.39M5.02M-1.26M-1.10M-0.80M4.61M13.84M-18.39M15.82M-0.65M-16.43M-3.49M1.47M1.87M-1.53M-0.03M0.28M0.01M2.00M
Change in Accured Expenses (Quarter)
2.38M0.37M2.74M2.04M5.65M15.62M2.18M-1.21M-0.15M20.77M-7.78M-12.53M-13.11M-26.39M-11.88M5.40M1.09M-1.21M-6.67M3.18M
Other Working Capital Changes (Quarter)
-0.00M-0.12M-0.32M-0.48M-0.49M-0.50M-0.52M-0.53M-0.54M-0.55M-0.57M-0.59M-0.60M-0.56M-0.03M0.02M-0.33M-0.38M
Investing Activities
Capital Expenditures (Quarter)
0.15M0.19M0.34M1.10M0.46M0.62M0.25M0.28M0.36M0.36M0.07M0.09M-0.02M0.02M0.01M0.02M0.02M0.09M
Change in Acquisitions & Divestments (Quarter)
24.91M36.00M84.50M34.00M66.00M123.50M56.70M147.92M74.00M130.00M75.00M65.00M60.00M62.00M64.00M60.00M60.00M31.00M
Cash from Investing Activities (Quarter)
-49.21M2.81M-99.31M4.46M84.04M-228.18M55.99M123.22M-108.09M20.93M0.82M-28.96M38.82M64.98M-43.66M22.99M5.24M29.47M36.26M-149.80M
Financing Activities
Other financing activities (Quarter)
0.16M0.14M200.90M-200.65M1.94M3.54M2.12M0.98M0.35M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
65.58M191.11M-0.38M
Change in Capital Stock
Shares Issued (Quarter)
5.34M1.77M8.53M8.58M8.48M10.06M3.17M9.95M9.82M4.74M5.15M8.34M7.73M9.62M4.87M9.60M9.41M11.44M11.33M
Net Equity Issued and Repurchased (Quarter)
132.72M0.21M
Misc.
Cash from Financing Activities (Quarter)
131.65M-1.06M200.46M-0.83M232.16M1.04M1.38M0.89M0.23M0.13M0.03M0.08M0.11M65.66M-0.03M191.61M-0.21M3.22M1.48M
Exchange Rate Effect (Quarter)
0.00M0.01M-0.07M-0.14M-0.37M0.51M0.07M-0.02M-0.13M0.24M-0.11M-0.04M0.24M-0.53M0.20M0.61M0.15M0.12M-0.11M-0.07M
Change in Cash (Quarter)
61.58M-26.49M60.44M-42.96M40.59M-45.21M52.04M133.20M-112.50M34.94M0.35M-95.55M-2.44M5.56M-17.62M-1.68M166.62M1.48M2.49M-179.81M
Free Cash Flow (Quarter)
-21.02M-28.43M-40.98M-47.57M-43.54M-50.32M-5.32M8.33M-5.53M13.20M-0.56M-66.67M-41.55M-59.03M-39.84M-25.27M-30.39M-27.99M-36.88M-31.42M
Net Cash Flow (Quarter)
61.58M-26.50M60.51M-42.83M40.96M-45.72M51.96M133.22M-112.37M34.71M0.46M-95.51M-2.67M6.08M-17.82M-2.29M166.47M1.36M2.60M-179.74M